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Abstract 
Background: Metabolic syndrome poses an increased global burden of disease and causes immense financial 
burden, warranting heightened public health attention. The present study assessed the prevalence and severity of 
cardiometabolic risk among foreign‑born versus US‑born blacks, while exploring potential gender‑based effects.
Methods: A total of 1035 patients from the Metabolic Syndrome Outcome Study (Trial registration: NCT01946659) 
provided sociodemographic, medical history, and clinical data. General Linear Model (GLM) was used to assess the 
effects of birthplace and gender on cardiometabolic parameters, adjusting for age differences in the sample.
Results: Of the sample, 61.6 % were foreign‑born blacks (FBB) and 38.4 % were US‑born blacks (USB). FBB had signifi‑
cantly lower BMI compared with USB (32.76 ± 0.35 vs. 35.41 ± 0.44, F = 22.57), but had significantly higher systolic 
blood pressure (136.70 ± 0.77 vs. 132.83 ± 0.98; F = 9.60) and fasting glucose levels than did USB (146.46 ± 3.37 vs. 
135.02 ± 4.27; F = 4.40). Men had higher diastolic BP (76.67 ± 0.65 vs. 75.05 ± 0.45; F = 4.20), glucose (146.53 ± 4.48 
vs. 134.95 ± 3.07; F = 4.55) and triglyceride levels (148.10 ± 4.51 vs. 130.60 ± 3.09; F = 10.25) compared with women, 
but women had higher LDL‑cholesterol (109.24 ± 1.49 vs. 98.49 ± 2.18; F = 16.60) and HDL‑cholesterol levels 
(50.71 ± 0.66 vs. 42.77 ± 0.97; F = 46.01) than did men.
Conclusions: Results showed that birthplace has a significant influence on cardiometabolic profiles of blacks with 
metabolic syndrome. Patients’ gender also had an independent influence on cardiometabolic profile.
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Background
Metabolic syndrome (MetS), a constellation of medi-
cal conditions that predispose individuals to increased 
risk of cardiovascular disease (CVD), Type 2 diabetes 
mellitus (T2DM) and all-cause mortality [1], increases 
global burden of disease and causes immense financial 
burden, warranting heightened public health attention 
[2–7]. MetS components include hyperglycemia (fast-
ing glucose ≥100  mg/dL), central or abdominal obesity 
(measured by waist circumference  ≥40 inches for men 
and  ≥35 inches for women), elevated blood pressure 
(systolic/diastolic blood pressure ≥130/85 mmHG), and 
atherogenic dyslipidemia (triglyceride levels  ≥150  mg/
dL of blood and HDL cholesterol  <40  mg/dL in men 
and  <50  mg/dL in women). MetS risk is greater among 
older adults and seems more prevalent among blacks rel-
ative to whites, although this may be gender dependent 
[8].
Among blacks, sociodemographic and environmen-
tal factors appear to be associated with the presence of 
MetS or its components. Using the Jackson Heart Study, 
researchers found that metabolic syndrome was posi-
tively correlated with neighborhood socioeconomic dis-
advantage, and lack of perceived safety was associated 
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intriguing hypothesis has emerged suggesting that place 
of birth or geographic residence could influence preva-
lence and severity of metabolic syndrome as well as its 
associated costs [10]. Evidence suggests an increase in 
metabolic syndrome related hospitalizations may be 
attributed in part to places of residence replete with per-
sistent environmental and organic pollutants that induce 
insulin resistance. Furthermore, since a disproportion-
ate number of blacks are born and/or reside in zip codes 
characterized by persistent environmental and organic 
pollutants relative to whites, it is likely that place of birth 
and residence contribute to poor cardiometabolic health 
[10].
We previously examined cardiometabolic risk pro-
files of US-born blacks (USB) versus foreign-born blacks 
(FBB), finding that higher rates of dyslipidemia and dia-
betes exist among USB relative to FBB [11]. However, 
detailed analyses of potential effects of place of birth on 
metabolic syndrome and its components could not be 
performed because of limited sample size, lack of clini-
cal metabolic syndrome data, and restricted age range 
in that study. The current study builds on our previous 
work, examining effects of place of birth on cardiomet-
abolic risks among blacks in the Metabolic Syndrome 
Outcome Study (MetSO). Specifically, we assessed the 
prevalence and severity of cardiometabolic risk factors 




Data (n =  1035) for the present investigation emanated 
from the MetSO study, which investigated sociodemo-
graphic, behavioral, psychosocial factors as well as health 
risks associated with metabolic syndrome among blacks 
in the primary-care setting. Data were obtained from 
four primary-care clinics in Brooklyn, NY affiliated with 
SUNY Downstate Medical Center.
Procedures
Study staff approached patients in primary-care clinics 
to solicit their participation. Those agreeing to partici-
pate provided informed consent and filled out a battery 
of tests including a questionnaire on sociodemographic 
profile, medical history, and use of medications. Clinical 
data including body mass index (BMI), blood pressure 
(BP), high-density lipoprotein cholesterol (HDL), low-
density lipoprotein cholesterol (LDL), and fasting plasma 
glucose (FPG) or hemoglobin (HbA1c) for those who had 
a diagnosis of diabetes were obtained from an electronic 
medical record at SUNY Downstate Medical Center, 
where all participants were initially registered [12]. The 
Institutional Review Boards (IRB) at New York University 
Langone Medical Center and SUNY Downstate Medical 
Center approved this study.
Statistical analysis
Frequency and measures of central tendency were used 
to describe the sample. In preliminary analyses, Pearson 
and Spearman correlations were used to explore rela-
tionships between variables of interest. General Linear 
Model (GLM) was used to assess the effects of birthplace 
and gender on cardiometabolic parameters, adjusting 
for age differences in the sample. In preliminary analy-
ses, income, education, and health risks did not have sig-
nificant co-varying effects on the dependent measures. 
Thus, only age effects were adjusted in the final model. 
The model also ascertained whether birthplace and gen-
der had a significant interaction with cardiometabolic 
factors. All analyses were performed using SPSS (version 
19.0; SPSS Inc. Chicago) statistical software.
Results
Of the 1035 patients, 986 reported their birthplace: 
607 (61.6 %) were FBB and 379 (38.4 %) were USB. Soci-
odemographic characteristics are reported in Table  1. 
Compared to USB, FBB patients were older and more 
likely to be married. FBB were less likely to have a high 
school diploma and more likely to report an annual 
household income less than $10,000 compared to USB. 
Smoking rates were strikingly dissimilar, with USB 
reporting a smoking rate 2.5 times higher than FBB.
Prevalence of physician diagnosed-conditions in the 
study sample is reported in Table 2. Descriptive analysis 
showed that FBB and USB had similar rates of hyperten-
sion, dyslipidemia and stroke. FBB had significantly lower 
rates of obesity (66.4 vs.74.9  %) and self-reported diag-
nosis of heart disease (26.5 vs. 37.5 %) compared to USB. 
However, FBB had significantly higher rates of diabetes 
(63.1 vs. 55.7 %) than USB.
Differences in individual cardiometabolic risk factors 
and components of metabolic syndrome are reported by 
birthplace (Table  3) and gender (Table  4). While there 
were no birthplace-based differences in lipid profile, 
HbA1c, and diastolic blood pressure, there were signifi-
cant between-group differences in BMI, systolic blood 
pressure, and fasting glucose levels. FBB had significantly 
lower mean BMI compared to USB (32.76 vs. 35.41  kg/
m2), but had significantly higher systolic blood pressure 
(136.70 vs. 132.83  mmHg) and fasting glucose (146.46 
vs. 135.02 mg/dL) levels than USB. Gender effect analy-
ses showed that there were no significant differences 
between men and women regarding BMI, systolic BP, or 
HbA1c. However, there were significant gender effects 
on diastolic BP, fasting glucose, and components of the 
lipid profile (see Table  4). Men had higher diastolic BP, 
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glucose, and triglyceride levels compared to women, but 
women had higher LDL-cholesterol and HDL-cholesterol 
levels (see Table 4).
Discussion
In this cross-sectional analysis of 1035 FBB and USB with 
metabolic syndrome in New York city, we found that 
rates of hypertension, dyslipidemia, and stroke did not 
differ by birthplace, which is consistent with previous 
studies. Likewise, we found that FBB had lower rates of 
obesity, heart disease, and smoking behavior relative to 
USB. However, critical cardiovascular risk factors, such 
as mean systolic blood pressure and rates of diabetes, 
were significantly higher among FBB compared to USB. 
This is a novel and unexpected finding in light of previous 
studies, including our own, that have demonstrated simi-
lar or lower cardiovascular risk among FBB compared to 
USB.
The finding that FBB had higher rates of diabetes is 
remarkable given that FBB, in this study, were less likely 
to be obese, and had significantly lower mean BMI com-
pared to USB. Our finding that FBB had higher rates of 
diabetes and were less likely to be obese compared to 
USB is incongruent with well-established evidence that 
higher BMI, obesity, and diabetes risk are positively asso-
ciated. One possible explanation is that FBB may differ in 
visceral adipose tissue (VAT) compared to USB, despite 
having lower BMI [13]. Visceral adipose tissue is thought 
to be an important determinant of metabolic risk, and 
may be more predictive of metabolic risk than BMI. Pre-
vious studies have found that VAT and BMI do not nec-
essarily correlate, particularly among blacks [13]. Thus, it 
is conceivable that FBB may have a more deleterious pat-
tern of fat distribution despite a lower BMI, which puts 
them at higher risk of diabetes compared to USB. Thus, 
one area of future research may be to examine differences 
in VAT between FBB and USB, and the underlying bio-
logic and psychosocial mechanisms for these potential 
differences.
Another point that warrants discussion is the higher 
systolic BP among FBB compared to USB in our study. 
This finding is slightly contrary to the east to west blood 
pressure gradient hypothesis described by Richard 
Cooper and colleagues (1997). This hypothesis states 
that blacks in eastern countries have lower hypertension 
rates compared to blacks in western countries, suggesting 
that industrialization, which is more common in western 
countries, might be responsible for variability in hyper-
tension rates [14]. One important consideration in inter-
preting the finding of a higher mean SBP among FBB is 
acculturation and duration of stay in the United States. 
Table 1 Sociodemographic and health risks among blacks 
in  the MetSO cohort (foreign-born blacks and  US-born 
blacks)
Smoking history, “Have you ever had more than 100 cigarettes ever”
Drinking, “In the past 30 days have you had at least one drink?”
Variables FBB USB Total sample
Age (years) 63.04 60.94 62.24
Sex (female)  % 69.1 68.1 68.7
Marital status  %
 Married 37.0 23.6 31.8
 Widowed 15.1 20.0 17.0
 Divorced 17.4 12.6 15.5
 Separated 10.6 9.0 10.0
 Never married 19.4 34.2 25.2
Education (< HS)  % 38.7 32.1 36.2
Family income (<10K) 45.5 40.3 43.5
Smoking history (yes)  % 19.0 47.1 29.2
Drinking (yes)  % 20.4 22.2 21.1
Table 2 Differences in  physician-diagnosed medical con-
ditions among blacks in the MetSO cohort based on birth-
place (foreign-born blacks and US-born blacks)
Hypertension, BP >140 mmHg; dyslipidemia, total cholesterol >200 mg/dL ad 
triglycerides >150 mg.dL; diabetes, type 2 diabetes; obesity, BMI >30 kg/m2 ; 
heart disease, ever had a physician diagnosis or history of heart disease; stroke, 
ever had a physician diagnosis or history of stroke
* p < 0.05; ** p < 0.01; *** p < 0.001
Variable FBB USB X2 p
Hypertension  % 91.9 92.6 0.182 0.670
Dyslipidemia  % 75.6 71.7 1.757 0.185
Diabetes  % 63.1 55.7 5.172 0.023*
Obesity  % 66.4 74.9 9.802 0.007**
Heart disease  % 26.5 37.5 12.885 <0.001***
Stroke  % 8.3 10.1 0.859 0.354
Table 3 Differences in  cardiometabolic risk profile based 
on birthplace among blacks with metabolic syndrome
BMI body mass index, systolic BP systolic blood pressure, diastolic BP diastolic 
blood pressure, LDL low-density lipoprotein, HDL high-density lipoprotein, 
Hba1c glycated hemoglobin
* p < 0.05; ** p < 0.01; *** p < 0.001
Variable FBB (Mean ± SE) USB (Mean ± SE) F p
BMI 32.76 ± 0.35 35.41 ± 0.44 22.57 <0.001***
Systolic BP 136.70 ± 0.77 132.83 ± 0.98 9.60 0.002**
Diastolic BP 76.54 ± 0.49 75.19 ± 0.62 2.91 0.088
Glucose 146.46 ± 3.37 135.02 ± 4.27 4.40 0.036*
LDL 104.91 ± 1.64 102.81 ± 2.08 0.62 0.430
HDL 47.00 ± 0.73 46.48 ± 0.92 0.19 0.661
Triglycerides 137.33 ± 3.40 141.36 ± 4.30 0.54 0.464
Hba1c 8.95 ± 0.48 8.15 ± 0.60 1.08 0.299
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It has been previously demonstrated that while FBB have 
better health status than USB for several indicators (e.g. 
self-rated health, health related quality of life, hyperten-
sion, diabetes and obesity) [15, 16], duration of stay in the 
US greater than 4 years among FBB was associated with 
worse health outcomes, comparable to the health sta-
tus of USB [17]. Borrell et  al. found that the prevalence 
of self-reported hypertension in FBB actually exceeded 
the prevalence of self-reported hypertension in USB, but 
only among FBB who had lived in the US for 10 years or 
more [16]. These findings, reinforced by the results of the 
current study, suggest that there may be factors for FBB 
that worsen health after spending time in the U.S. Such 
a possibility calls for further population-based investiga-
tion to understand the widening disparity in cardiovas-
cular outcomes among FBB residing in the US as well 
as development of population-specific interventions We 
also found a significant gender effect on cardiometabolic 
risk in our diverse sample of black participants after con-
trolling for age. Specifically, there were gender-based dif-
ferences in fasting glucose levels and lipid profile. Our 
finding of higher glucose levels among men is consist-
ent with other large–scale studies such as NHANES and 
MESA [18], which found similar gender-based differ-
ences in glucose levels. This gender-based trend is also 
consistent with findings from the Jackson Heart Study, 
a longitudinal cohort study of US blacks, which consist-
ently showed lower fasting glucose levels among women, 
regardless of glucose classification (normal, impaired 
fasting glucose, and diabetes) [19]. With regard to lipids, 
women had higher LDL and HDL levels, but lower tri-
glyceride levels. Other studies have found, including 
Multi-Ethnic Study of Atherosclerosis (MESA) [20] and 
the Jackson Heart Study [21], that black women are less 
likely to have a dyslipidemic profile (low HDL and high 
triglycerides) than other groups. In fact, it has been pro-
posed that this tendency to have a more favorable lipid 
profile may undermine cardiovascular risk assessment 
in black women, particularly among women with meta-
bolic syndrome [22, 23]. A recent study by McIntosh 
et al. found that among a sample of 254 women of which 
116 were black, only less than 1  % met criteria for dys-
lipidemia [24]. Yet, black women have high rates of obe-
sity, hypertension and Type 2 diabetes, thus increasing 
their cardiovascular risk, despite having a more favorable 
lipid profile. These factors should be taken into account 
in cardiovascular risk assessment and stratification for 
black women, particularly among those with metabolic 
syndrome.
Despite the strengths of having a robust number of for-
eign-born and US-born blacks in our sample, our study 
has some limitations. First, we did not collect informa-
tion on dietary practices, such as eating habits and food 
intake, or family history of hypertension and diabetes—
all critical cardiovascular risk factors. Family history may 
provide insight on the noted differences in blood pressure 
and diabetes between FBB and USB. Second, information 
on country of birth, duration of stay and acculturation 
were not available for examination in this study. These 
and other psychosocial factors that may be unique to FBB 
may elucidate potential mechanisms for the higher blood 
pressure and diabetes risk noted in this population.
Conclusion
In conclusion, we found that FBB have lower levels of 
obesity, similar rates of hypertension, dyslipidemia, 
stroke history, but higher rates of diabetes, history of 
heart disease, and higher systolic blood pressure com-
pared to USB. These novel findings require further inves-
tigation and may have implications for addressing heath 
disparities in cardiovascular disease risk and outcomes.
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